The Nelson Report

Facing its lowest donation levels in two decades, the Red Cross offers a Super Bowl trip to spur giving as hospitals risk rationing critical blood supplies.

The electric vehicle maker is diversifying into the high-stakes world of AI, partnering with a top university to develop quadruped security robots.

Northann Corp. stock soars on a major retail partnership, but can its innovative 3D printing tech overcome deep financial woes and a delisting threat?

ASUS sets the stage for CES 2026 with a dual-screen Zenbook DUO and a durable ProArt laptop co-engineered with GoPro, all powered by a new AI vision.

The biopharma investment giant has now acquired 100% of the royalty stream for Roche's blockbuster SMA drug, a strategic move years in the making.

The high-yield fund declared a major distribution while pivoting to safer CLO assets, signaling a new balance between aggressive income and capital preservation.

HIZERO is launching a fleet of new cleaning gadgets at CES 2026, led by a handheld device that cleans, washes, and dries without noisy suction.

Canadian firms are pulling back on hiring for 2026, not due to the economy, but a critical lack of skilled talent. A new survey reveals the growing crisis.

A new AI assistant is being piloted in the UAE, promising to cut doctor paperwork by 50% and give patients more face-to-face attention.

In a strategic move, industry leader Ashish Malik joins DunhamTrimmer's leadership, set to guide the firm's dominance in the booming biologicals market.

The digital signage firm's new virtual environment lets users explore a full installation, from emergency alerts to video walls, on any device.

The drone taxi market is projected to soar to $3.8 billion by 2032. But can regulators, infrastructure, and public trust keep up with the hype?

A new poll shows 81% of Americans fear tariffs will delay local projects, creating a funding crisis as costs rise and public opposition to new taxes grows.

A new VAB report alleges Nielsen's 'Big Data + Panel' currency is unstable and inaccurate, revealing massive audience variances that threaten media deals.

A new partnership uses licensed 5G spectrum to create a private highway for drones, promising unprecedented reliability for first responders and critical missions.

IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.

Verastem Oncology taps industry heavyweights for its leadership, signaling a bold new strategy to accelerate its cancer pipeline and grow its market share.

DoubleVerify's new partnership with TikTok promises deeper ad insights, but what does it signal for the future of platform transparency and ad spend?

A new report on 1 billion texts reveals when to send, what to say, and why SMS is beating email. Here's the data-driven strategy for 2026.

A new software-defined radio isn't just a product launch; it's a strategic masterstroke, embracing open standards to reshape electronic warfare and investment.